See more : Radisson Mining Resources Inc. (RDS.V) Income Statement Analysis – Financial Results
Complete financial analysis of Celularity Inc. (GXGXW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Celularity Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Brillia Inc (BRIA) Income Statement Analysis – Financial Results
- Super Fine Knitters Limited (SKL.BO) Income Statement Analysis – Financial Results
- Polytec Holding AG (P4N.DE) Income Statement Analysis – Financial Results
- AZZ Inc. (AZZ) Income Statement Analysis – Financial Results
- Jet.AI Inc. (JTAIZ) Income Statement Analysis – Financial Results
Celularity Inc. (GXGXW)
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 22.77M | 17.98M | 21.34M | 14.28M | 21.15M | 17.55M |
Cost of Revenue | 16.02M | 19.67M | 9.65M | 4.93M | 6.32M | 6.56M |
Gross Profit | 6.76M | -1.69M | 11.68M | 9.35M | 14.82M | 11.00M |
Gross Profit Ratio | 29.66% | -9.40% | 54.76% | 65.46% | 70.10% | 62.66% |
Research & Development | 30.47M | 78.36M | 88.35M | 52.71M | 46.05M | 29.06M |
General & Administrative | 50.53M | 65.86M | 71.09M | 30.57M | 564.34K | 0.00 |
Selling & Marketing | 44.00K | 163.00K | 252.00K | 764.00K | 1.16M | 0.00 |
SG&A | 50.58M | 66.02M | 71.34M | 31.34M | 1.68M | 1.10K |
Other Expenses | 118.00M | 2.19M | 50.75M | 3.39M | 0.00 | 0.00 |
Operating Expenses | 199.04M | 146.58M | 159.69M | 87.44M | 1.68M | 1.10K |
Cost & Expenses | 215.06M | 166.24M | 169.35M | 92.37M | 1.68M | 1.10K |
Interest Income | 320.00K | 365.00K | 332.00K | 370.00K | 694.00K | 628.00K |
Interest Expense | 3.02M | 0.00 | 3.17M | 2.35M | 0.00 | 0.00 |
Depreciation & Amortization | 9.32M | 9.38M | 8.82M | 8.17M | 6.19M | 4.79M |
EBITDA | -183.95M | 23.58M | -88.11M | -202.41M | -1.68M | -1.10K |
EBITDA Ratio | -807.81% | -785.17% | -454.31% | -458.40% | -7.96% | -0.01% |
Operating Income | -192.29M | -25.60M | -148.01M | -78.09M | -1.68M | -1.10K |
Operating Income Ratio | -844.44% | -142.42% | -693.75% | -546.93% | -7.96% | -0.01% |
Total Other Income/Expenses | -4.00M | 39.81M | 8.96M | -61.01M | 7.11M | 2.00 |
Income Before Tax | -196.29M | 14.21M | -100.10M | -212.93M | 6.55M | -1.10K |
Income Before Tax Ratio | -862.00% | 79.03% | -469.17% | -1,491.34% | 30.96% | -0.01% |
Income Tax Expense | 10.00K | 13.00K | 20.00K | -4.70M | 668.23K | 21.30M |
Net Income | -196.30M | 14.19M | -100.12M | -208.23M | 5.88M | -1.10K |
Net Income Ratio | -862.04% | 78.95% | -469.27% | -1,458.42% | 27.80% | -0.01% |
EPS | -11.02 | 1.01 | -8.04 | -22.67 | 2.46 | 0.00 |
EPS Diluted | -11.02 | 0.90 | -8.08 | -22.67 | 2.46 | 0.00 |
Weighted Avg Shares Out | 17.81M | 15.77M | 12.45M | 9.19M | 2.39M | 35.94M |
Weighted Avg Shares Out (Dil) | 17.81M | 14.98M | 12.39M | 9.19M | 2.39M | 35.94M |
No news found for: GXGXW
Source: https://incomestatements.info
Category: Stock Reports